Adjuvant chemo following chemoradiation as treatment for locally advanced cervical cancer compared to chemoradiation alone

Tislelizumab in oesophageal cancer after systemic therapy

HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in MIBC patients

CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC

PEACE-1: Abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo mCSPC

CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma

Can multiple endpoints in MM clinical papers create new insights?

LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor

Highlights from ASCO 2021

OncoAlert and ecancer ASCO roundup - Day 3

PANAMA: Maintenance 5FU/LV plus panitumumab or 5FU/LV alone in RAS wildtype mCRC

OncoAlert and ecancer ASCO roundup - Day 2